@svarre001 point me to a non-negative, non-cynical tweet from you in the past 6 months. Or even 12 months.
You gotta change your outlook just a little bit of not much.
You've chosen to invest in a sector that is not anyways rewarding. Deal with it!
@RNAiAnalyst I'm positive you're still ~50% underwater on your holding of $NVAX.
And if you don't want to get into personal arguments, why are you posting on a public platform?
Scribble something in your paper pad and close it. Paper won't argue with you.
@BillGoldfarb @pawcio2009@dhovekamp42@BioEqman Are you looking for an answer more complex than, "because @dhovekamp42 is just as big of a moron like the rest of the bunch at $AFMD"?
Must be a German thing to not admit mistake and blindly follow on.
@biopharmacaster@TradingBio@wyv_123 Disagree with your current/past panicky thoughts. You seem to think every step is bad.
The question is WHY did CFIUS asked to refile?
So they can reject?
They've had months. Enough time to reject if that's what they wanted.
Why do they care if clock ran out? That's what clocks do
@TradingBio@wyv_123 You are usually very precise, but this makes no sense.
*CFIUS did not accept the refile*, rather CFIUS accepted the refile which CFIUS requested.
So CFIUS requested, parties refiled.
CFIUS would not have requested refile if it saw no prospect to reach and agreement.
$FSTX
@topologic_apple@adar170 This is absolutely insane.
What DOES $FSTX have that poses suchhhhhhh a huge national security issue?
These administration is off it's fing rockers!
OTOH, I think $FSTX might need to raise cash, but if they're sitting on such precious tech, than they'll do ok long term.
@semodough What are the chances that this is a big shorts play via rumors to cash in before $FSTX deal comes through and they lose pants?
Maybe by Jan 31. Maybe one more extension.
Surely such short plays can't happen in this God's honest country where manipulation is an unheard of a word.
@gigatroll95 Much better answer than 99.9% here.
Good for the patients and above all good for investors if this stock can ever execute in any meaningful way.
Haven't seen any meaningful clinical update since, well IPO. But good if it does.
Until that happens it's all wises in the well.
@GT59JN $AFMD is always cheap.
Every. Year. There. Is. An. Opportunity. To. Buy. $AFMD . For. Under. $5.
EVERY. YEAR.
Why the hell would I buy this crap?